Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: An in vitro study

European Journal of Histochemistry

Volumn 61, Issue 1, 2017, Pages 1-13

  Giacoppo, Sabrina ^a   Gugliandolo, Agnese ^a   Trubiani, Oriana ^b   Pollastro, Federica ^c   Grassi, Gianpaolo ^d   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b University G D Annunzio of Chieti Pescara   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d Research Centre for Industrial Crops   (Italy)

Author keywords

Apoptosis; Cannabigerol; Immunohistochemistry; Oxidative stress; RAW264.7 macrophages

Indexed keywords

3-NITROTYROSINE; BAX PROTEIN, MOUSE; BCL2 PROTEIN, MOUSE; CANNABIGEROL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; INDOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; IODOPRAVADOLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NOS2 PROTEIN, MOUSE; PARP1 PROTEIN, MOUSE; PIPERIDINE DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PYRAZOLE DERIVATIVE; RIMONABANT; SOD1 PROTEIN, MOUSE; TYROSINE;

AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; MACROPHAGE; METABOLISM; MOUSE; OXIDATIVE STRESS; RAW 264.7 CELL LINE;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CANNABINOIDS; HYDROGEN PEROXIDE; INDOLES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PIPERIDINES; POLY (ADP-RIBOSE) POLYMERASE-1; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZOLES; RAW 264.7 CELLS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SUPEROXIDE DISMUTASE-1; TYROSINE;

EID: 85012302509     PISSN: 1121760X     EISSN: 20388306     Source Type: Journal    
DOI: 10.4081/ejh.2017.2749     Document Type: Article

References (45)

1. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
2. Kim GH, Kim, JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol 2015;24:325-40.
3. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89-96.
4. Sosa V, Moline T, Somoza, R, Paciucci R, Kondoh H, Me LL. Oxidative stress and cancer: an overview. Ageing Res Rev 2013;12:376-90.
5. Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004;10:1611-26.
6. Hill AJ, Williams CM, Whalley BJ, Stephens GJ. Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 2012;133:79-97.
7. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev 2010;62:588-631.
8. Buckley NE. The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 2008;153:309-18.
9. Izzo AA, Borrelli F, Capasso R., Di Marzo V, Mechoulam, R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009;30:515-27
10. Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, et al. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 2013;85:1306-16.
11. Ruhaak LR, Felth J, Karlsson PC, Rafter JJ, Verpoorte R, Bohlin L. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa. Biol Pharm Bull 2011;34:774-8.
12. Granja AG, Carrillo-Salinas F, Pagani A, Gomez-Canas M, Negri R, Navarrete C, et al. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis. J Neuroimmune Pharmacol 2012;7:1002-16.
13. Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Munoz E, Sagredo O. Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics 2015;12:185-99.
14. Diaz-Alonso J, Paraiso-Luna J, Navarrete C, Del Rio C, Cantarero I, Palomares B, et al. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease. Sci Rep 2016;6:29789.
15. Gieche J, Mehlhase J, Licht A, Zacke T, Sitte N, Grune T. Protein oxidation and effects of PMA activation. Biochim Biophys Acta 2001;1538:321-8.
16. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014;20:1126-67.
17. Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 2011;51:267-88.
18. Boutros T, Chevet E, Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 2008;60:261-310.
19. Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct 2011;2011:792639.
20. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000;6:441-8.
21. B Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci, O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012;5:9-19.
22. Tong WM, Cortes U, Wang ZQ. Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochim Biophys Acta 2001;1552:27-37.
23. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:S31-8.
24. Jiang T, Sun Q, Chen S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog Neurobiol 2016; 147:1-19.
25. Pitzschke A, Hirt H. Mitogen-activated protein kinases and reactive oxygen species signaling in plants. Plant Physiol 2006;141:351-6.
26. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 2011;7:504-11.
27. Forman HJ. Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic Biol Med 2007;42:926-32.
28. Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 2006;399:91-5.
29. Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med 2011;51: 1054-61.
30. Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C. Neuroprotective roperties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 2002;80: 448-56.
31. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4.
32. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5.
33. Konishi H, Tanaka M, Takemura Y, et al. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 1997;94:11233-7.
34. McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 2006;8:1775-89.
35. Ruffels J, Griffin M, Dickenson JM. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SHSY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death. Eur J Pharmacol 2004;483:163-73.
36. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. BioFactors 2003;17:287-96.
37. Brown MD, Sacks DB. Protein scaffolds in MAP kinase signalling. Cell Signal 2009;21:462-9.
38. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg, S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997;198:35-49.
39. Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 1996;27: 19238-42.
40. Ross RA, Brockie HC, Pertwee RG. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur J Pharmacol 2000;401:121-30.
41. Merighi S, Gessi S, Varani K, et al. Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide. Br J Pharmacol 2012;165:1773-88.
42. Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XFS. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun 2014;5:3446.
43. Chiarugi A. Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci 2002;23:122-9.
44. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ Activation of mitogenactivated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996;271:4138-42.
45. Fujii M, Sherchan P, Soejima Y, Hasegawa Y, Flores J, Doycheva D, et al. Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Exp Neurol 2014;261:396-403.